Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS1 | P23219 | 1/20 | 0.40 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.40 |
| ▸ | PRKDC | P78527 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12546341 | 0.80 | PTGS1 (0.43) | PTGS1PTGS2PRKDC | |
| SCHEMBL12546244 | 0.79 | PTGS1 (0.42) | PTGS1PTGS2PRKDC | |
| SCHEMBL12567044 | 0.76 | ALDH1A1 (0.33) | PTGS1PTGS2 | |
| SCHEMBL21952789 | 0.76 | PTGS1 (0.36) | PTGS1PTGS2PRKDC | |
| SCHEMBL12567041 | 0.73 | PTGS2 (0.38) | PTGS1PTGS2PRKDC | |
| SCHEMBL16440507 | 0.72 | PTGS1 (0.31) | PTGS1PTGS2 | |
| SCHEMBL16687361 | 0.72 | PRKDC (0.33) | PTGS1PTGS2PRKDC | |
| SCHEMBL18975440 | 0.71 | PTGS2 (0.38) | PTGS1PTGS2PRKDC | |
| SCHEMBL12566026 | 0.71 | PRKDC (0.33) | PRKDC | |
| SCHEMBL19214002 | 0.70 | PTGS1 (0.30) | PTGS1PTGS2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10981936-B2 | Oligomeric perylene diimide non-fullerene acceptors via direct (hetero)arylation cross-coupling reactions | UTI LIMITED PARTNERSHIP (CA) | 2021-04-20 | — | — | US | disclosed |
| US-20200262846-A1 | Oligomeric Perylene Diimide Non-Fullerene Acceptors via Direct (Hetero)Arylation Cross-Coupling Reactions | UTI LIMITED PARTNERSHIP (CA) | 2020-08-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10981936-B2 | Oligomeric perylene diimide non-fullerene acceptors via direct (hetero)arylation cross-coupling reactions | DDT, PPIE, PPOX | PTGS1 3734/4885PTGS2 1537/4885PRKDC 1347/4885 |
| US-20200262846-A1 | Oligomeric Perylene Diimide Non-Fullerene Acceptors via Direct (Hetero)Arylation Cross-Coupling Reactions | DDT, PPIE, PPOX | PTGS1 3734/4885PTGS2 1537/4885PRKDC 1347/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.